Skip to content

Axogen AXGN Finished goods

Finished goods at other companies

Stryker logo
StrykerSYK
$3.51B0.0%
IAR
Integra LifeSciencesIART
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.26B+110%
Enterprise value$2.2B+91.4%
P/S9.5×+4.0×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's finished goods?
Axogen (AXGN) reported finished goods of $41.81M in Q1 2026.
How has Axogen's finished goods changed year-over-year?
Axogen's finished goods increased by 43.3% year-over-year, from $29.18M to $41.81M.
What is the long-term trend for Axogen's finished goods?
Over 5 years (2020 to 2025), Axogen's finished goods has grown at a 33.4% compound annual growth rate (CAGR), from $8.88M to $37.54M.